What should men know about prostate-specific antigen screening before giving informed consent?
The American Journal of MedicinePublished 1 October 1998Open access
Evelyn C.Y Chan, Daniel P. Sulmasy
Citations98
SJR quartileQ1
SJR score1.00
SNIP1.04
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The findings provide content for informed consent for PSA screening, and the method may be useful for other controversial tests.
Abstract
Physicians and patients agree upon some facts that men should know about PSA screening before giving informed consent. However, physicians fail to emphasize other facts that patients find important. Physicians may differ by expertise; patients, by experience. Our findings provide content for informed consent for PSA screening, and our method may be useful for other controversial tests.
Keywords
MedicineHealth Professions
Journal of Legal MedicineA history and theory of informed consent
2,348 Citations1986Marshall B. Kapp
New England Journal of MedicineThe Use and Interpretation of Commercial<i>APC</i>Gene Testing for Familial Adenomatous Polyposis
496 Citations1997Francis M. Giardiello, Jill D. Brensinger +7 more
Patients who underwent genetic tests for familial adenomatous polyposis often received inadequate counseling and would have been given incorrectly interpreted results, and physicians should be prepared to offer genetic counseling if they order genetic tests.
Clinical GerontologistGuide to Clinical Preventive Services
448 Citations1993David Haber
The physician's degree of resourcefulness, i.e., the ability to deal skillfully and promptly with new situations, is important for changing the health behaviors of patients within the constraints of a brief office visit, was in short supply among primary care physicians selected for their interest in preventive medicine.
Annals of Internal MedicineProstate Cancer Screening: What We Know and What We Need To Know
276 Citations1993Barnett S. Kramer, Martin L. Brown +3 more
A number of scientific and economic uncertainties exist about the wisdom of widespread implementation of the PSA assay for screening, and these uncertainties justify a definitive randomized trial to determine whether screening for prostate cancer would reduce mortality from the disease.
Journal of General Internal MedicineThe importance of patient preference in the decision to screen for prostate cancer
273 Citations1996Ann Barry Flood, John E. Wennberg +4 more
Preference regarding cancer screening and treatment is greatly affected by information about medical uncertainties, and informed patient choices vary, PSA screening decisions should incorporate individual preferences.
New England Journal of MedicineScreening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
243 Citations1995Steven H. Woolf
Levels of prostate-specific antigen, a serine protease, are elevated in most men with clinically important prostate cancer and measuring them is the best means for early detection of the disease.
Archives of Internal MedicineTwo Models of Implementing Informed Consent
238 Citations1988Charles W. Lidz
Two different ways in which informed consent can be implemented are described: the event model treats informed consent as a procedure to be performed once in each treatment course, and the process model tries to integrate informing the patient into the continuing dialogue between physician and patient that is a routine part of diagnosis and treatment.
PubMedGenetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
215 Citations1997Gail Geller, Jeffrey R. Botkin +8 more
The Journal of UrologyProstate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute
213 Citations1994John K. Gohagan, Philip C. Prorok +2 more
The prostate, lung, colorectal and ovarian cancer (randomized, controlled) screening trial of the National Cancer Institute, to include 74,000 men and women, has a design power of 90% to determine a 20% reduction of prostate cancer mortality from a baseline and 3 subsequent annual screens using prostate specific antigen and digital rectal examination.
New England Journal of MedicineInformed (but Uneducated) Consent
210 Citations1972Franz J. Ingelfinger
Archives of Internal MedicineThe Impact of Informed Consent on Patient Interest in Prostate-Specific Antigen Screening
208 Citations1996Andrew M. D. Wolf
Among primary care patients of predominantly lower socioeconomic status, those who received informed consent were significantly less interested in PSA screening than those who did not, highlighting the importance of apprising patients of the associated benefits, burdens, and uncertainties and allowing them to participate in the screening decision.
JAMAScreening for Prostate Cancer
199 Citations1994Murray Krahn
The analysis does not support using PSA, TRUS, or DRE to screen asymptomatic men for prostatic cancer, and Screening may result in poorer health outcomes and will increase costs dramatically.
The Journal of UrologyThe Prostate Cancer Intervention Versus Observation Trial: A Randomized Trial Comparing Radical Prostatectomy Versus Expectant Management for the Treatment of Clinically Localized Prostate Cancer
190 Citations1994Timothy J Wilt, Michael K. Brawer
The Prostate Cancer Intervention Versus Observation Trial (PIVOT) is a randomized controlled trial sponsored by the Department of Veterans Affairs and the National Cancer Institute to determine which of 2 strategies is superior for managing clinically localized prostate cancer of all histological grades.
UrologyKnowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening
169 Citations1995Wendy Demark‐Wahnefried, Tara S. Strigo +5 more
There are a number of similarities among black and white men regarding knowledge and beliefs related to prostate cancer, however, important differences in access to screening, perception of the disease and its treatment, and knowledge of risk factors exist between racial groups and represent significant barriers to early detection among African Americans.
Palgrave Macmillan UK eBooksMaking Health Care Decisions
158 Citations1992Miriam K. Mills
This chapter deals with an approach taken to evaluate various treatment protocols based on a variety of criteria to make one’s thinking manifest.
JAMAGenetic Testing for Susceptibility to Adult-Onset Cancer
136 Citations1997Gail Geller
The Task Force on Informed Consent recommends that informed consent for cancer susceptibility testing be an ongoing process of education and counseling in which providers elicit participant, family, and community values and disclose their own.
PubMedThe elderly patient and informed consent. Empirical findings.
103 Citations1984Bárbara Stanley, J R Guido +2 more
Critical Care MedicineInformed consent in theory and practice
79 Citations1989Charles L. Sprung, Bruce J. Winick
American Journal of RoentgenologyInformed consent for percutaneous lung biopsy: comparison of two consent protocols based on patient recall after the procedure.
53 Citations1995Charles S. White, Andrew C. Mason +2 more
The standard consent procedure for lung biopsy appears inadequate when patients' recall of procedure risks later is used as a measure of the patients' comprehension and may be improved substantially by teaching patients to recite the procedure risks to the physician as part of the informed consent protocol.
PubMedScreening by the prostate-specific antigen test: what do the patients know?
40 Citations1996Pamela Diefenbach, Patricia A. Ganz +2 more
Either patients forget information about the PSA test or providers do not tell patients they are being screened for cancer, and further research and interventions are needed to improve patient knowledge and understanding about this prostate cancer screening test.
PubMedProstate cancer in Florida: knowledge, attitudes, practices, and beliefs.
39 Citations1995Clyde B. McCoy, Robert S. Anwyl +4 more
More than 60% of the 897 respondents believed that a person with prostate cancer had an 80% or greater chance for cure, yet only 67% reported ever having a digital rectal examination, and physicians ranked first whereas family and friends ranked near the bottom on a list of some 11 sources.
The American Journal of MedicinePredictors of Interest in Prostate-Specific Antigen Screening and the Impact of Informed Consent
38 Citations1997Andrew M. D. Wolf, John T. Philbrick +1 more
Patients given information about PSA screening and prostate cancer are more likely to be interested in screening if they have a family history of prostate cancer, are younger, or otherwise consider themselves susceptible to developing prostate cancer.
PubMedPublic awareness of prostate cancer and the prostate-specific antigen test.
33 Citations1994Arch G. Mainous, M D Hagen
It is found that adults remain poorly informed about prostate cancer and possible case-finding strategies, and if the American Cancer Society's (ACS) early detection recommendations are to succeed, attention should focus on improving the public's awareness of currently available methods for early detection of prostate cancer.
CancerStrategies to overcome barriers to early detection of cancer among older adults
32 Citations1994Lisa V. Rubenstein
The barriers older women face regarding mammography screening and the barriers that older men face in terms of screening for prostate cancer and preventive health in general are addressed.
PubMedScreening for prostate cancer. How can patients give informed consent?
14 Citations1993K G Marshall
Many urologists in North America are increasingly enthusiastic about prostatic cancer screening, but doctors really should not screen by either method without patients' informed consent.
JAMAInformed Consent for Tests for Prostate Cancer
3 Citations1995Kenneth G. Marshall
It is clear that significant morbidity is associated with all modalities of managing localized prostate cancer, including surgery, radiation, and observation, and there is no way of avoiding this and a conceptually simple method is to give the patient the opportunity of completely opting out of the prostate cancer case-finding process.